LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Expenditure | ₹481 Cr | ₹421 Cr | ₹377 Cr | ₹337 Cr | ₹321 Cr |
What is the latest Total Expenditure of LINCOLN PHARMACEUTICALS ?
Year | Total Expenditure |
---|---|
Mar2024 | ₹481 Cr |
Mar2023 | ₹421 Cr |
Mar2022 | ₹377 Cr |
Mar2021 | ₹337 Cr |
Mar2020 | ₹321 Cr |
How is Total Expenditure of LINCOLN PHARMACEUTICALS Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2024 | ₹481 Cr | 14.14 | |
Mar2023 | ₹421 Cr | 11.81 | |
Mar2022 | ₹377 Cr | 11.76 | |
Mar2021 | ₹337 Cr | 5.00 | |
Mar2020 | ₹321 Cr | - |
Compare Total Expenditure of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,536.0 Cr | -8.1% | -16.5% | 26.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -8.1% |
-16.5% |
26.3% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses